PMID- 19699789 OWN - NLM STAT- MEDLINE DCOM- 20100217 LR - 20091019 IS - 1872-7573 (Electronic) IS - 0378-8741 (Linking) VI - 126 IP - 1 DP - 2009 Oct 29 TI - The inhibitory effect of Gynostemma pentaphyllum on MCP-1 and type I procollagen expression in rat hepatic stellate cells. PG - 42-9 LID - 10.1016/j.jep.2009.08.012 [doi] AB - AIM OF THE STUDY: Gynostemma pentaphyllum is a popular folk medicine that has been used for treatment of hepatitis in Asia. Our previous study demonstrates that Gynostemma pentaphyllum n-butanol extract inhibits the onset and improves the recovery of CCl(4)-induced liver fibrogenesis in rats and inhibits PDGF-induced rat hepatic stellate cells (HSCs) proliferation. In this study, the effect of Gynostemma pentaphyllum extract on cytokines and type I procollagen expression was analyzed. MATERIALS AND METHODS: Rat HSCs were treated with PDGF, Gynostemma pentaphyllum n-butanol extract, RP-18-Gyp fraction, rapamycin or vehicle. Rat cytokine antibody array chip or ELISA kit was used for cytokines detection. Intracellular protein expression was detected by Western blotting, mRNA expression was analyzed by RT-PCR. RESULTS: RP-18-Gyp fraction is the more purified gypenosides fraction from Gynostemma pentaphyllum n-butanol extract. In cell proliferation, the inhibitory effect of 200 microg/ml RP-18-Gyp fraction is similar to 500 microg/ml Gynostemma pentaphyllum n-butanol extract. Furthermore, both of them have the ability of decreasing monocyte chemoattractant protein-1 (MCP-1) mRNA expression and protein release and inhibiting type I procollagen protein expression. CONCLUSIONS: Both of Gynostemma pentaphyllum n-butanol extract and its more purified RP-18-Gyp fraction have the biological activities in the inhibition of cell proliferation, MCP-1 release and type I procollagen expression in rat HSCs. These data could provide the evidence to support for the traditional use of Gynostemma pentaphyllum in hepatitis. FAU - Chen, Ming-Ho AU - Chen MH AD - Department of Chinese Medicine, Chiayi Christian Hospital, Chiayi, Taiwan. FAU - Wang, Qwa-Fun AU - Wang QF FAU - Chen, Lih-Geeng AU - Chen LG FAU - Shee, Jia-Jen AU - Shee JJ FAU - Chen, Jung-Chou AU - Chen JC FAU - Chen, Ke-Yu AU - Chen KY FAU - Chen, Shu-Hsin AU - Chen SH FAU - Su, Jyan-Gwo J AU - Su JG FAU - Liu, Yi-Wen AU - Liu YW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090821 PL - Ireland TA - J Ethnopharmacol JT - Journal of ethnopharmacology JID - 7903310 RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Collagen Type I) RN - 0 (Cytokines) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Plant Extracts) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (gypenoside) SB - IM MH - Animals MH - Cell Proliferation/drug effects MH - Chemokine CCL2/*metabolism MH - Collagen Type I/*metabolism MH - Cytokines/metabolism MH - Drugs, Chinese Herbal/pharmacology MH - Gene Expression/drug effects MH - Gynostemma/chemistry MH - Hepatic Stellate Cells/*drug effects/metabolism MH - Male MH - Plant Extracts/chemistry/pharmacology MH - Platelet-Derived Growth Factor/pharmacology MH - Rats MH - Rats, Sprague-Dawley EDAT- 2009/08/25 09:00 MHDA- 2010/02/18 06:00 CRDT- 2009/08/25 09:00 PHST- 2008/09/09 00:00 [received] PHST- 2009/08/11 00:00 [revised] PHST- 2009/08/12 00:00 [accepted] PHST- 2009/08/25 09:00 [entrez] PHST- 2009/08/25 09:00 [pubmed] PHST- 2010/02/18 06:00 [medline] AID - S0378-8741(09)00507-8 [pii] AID - 10.1016/j.jep.2009.08.012 [doi] PST - ppublish SO - J Ethnopharmacol. 2009 Oct 29;126(1):42-9. doi: 10.1016/j.jep.2009.08.012. Epub 2009 Aug 21.